|
시장보고서
상품코드
2112273
동종골이식편 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Bone Allografts Market Size, Share & Trends Analysis Report By Product (Structural Allografts, Demineralized Bone Matrix (DBM)), By Application (Spinal Fusion, Trauma & Long Bone), By End-use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
골 동종 이식편 시장 요약
세계의 동종골이식편 시장 규모는 2025년에 20억 달러로 평가되며, 2026년 21억 달러에서 2033년에는 30억 달러로 확대하며, 2026-2033년의 CAGR은 5.3%에 달할 것으로 예측됩니다. 2025년에는 북미가 42.4%라는 최대 시장 점유율을 차지했습니다. 고령 인구 증가, 의료비 급등, 그리고 의료 종사자들의 동종 골 이식재 채택 확대 등이 이 업계의 성장을 지원하는 요인으로 작용하고 있습니다.
관절 재건술이나 척추 고정술 등의 외과수술 건수 증가도 그 요인으로 꼽힙니다. 또한 예측 기간 중 첨단 골이식술의 개발과 골절 발생 빈도의 증가도 시장 성장을 지원할 것으로 예상됩니다. 예를 들어 2026년 2월, 메드트로닉(Medtronic)은 자사의 ‘INFUSE 골이식재’의 적응증을 1단계 및 2단계 TLIF(경추간판 고정술) 척추 수술로 확대하는 것에 대해 FDA의 승인을 획득하여, 척추 고정술의 치료 선택지를 넓혔습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 동종골이식편 시장 : 변수, 동향, 범위
제4장 동종골이식편 시장 부문 분석 : 제품별, 2021-2033년
제5장 동종골이식편 시장 부문 분석 : 용도별, 2021-2033년
제6장 동종골이식편 시장 부문 분석 : 최종 사용별, 2021-2033년
제7장 동종골이식편 시장 부문 분석 : 지역별, 2021-2033년
제8장 경쟁 구도
KSA 26.08.19Bone Allografts Market Summary
The global bone allografts market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.0 billion in 2033, at a CAGR of 5.3% from 2026 to 2033. North America held the largest market share of 42.4% in 2025. The growing geriatric population, rising healthcare costs, and increasing healthcare provider adherence to allografts are some factors propelling the industry's growth.
The rising number of surgical procedures, such as joint reconstruction and spinal fusion surgeries. In addition, during the forecast period, the development of sophisticated bone graft procedures and an increase in the frequency of bone fractures are also anticipated to propel market growth. For instance, in February 2026, Medtronic received FDA approval to expand indications of its INFUSE Bone Graft for one- and two-level TLIF spine procedures, broadening treatment options for spinal fusion surgeries.
Global Bone Allografts Market Report Segmentation
This report forecasts revenue growth at the global, regional & country level and provides an analysis of industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global bone allografts market report based on product, application, end use, and region:
- Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Structural Allografts
- Cortical Allografts
- Cancellous Allografts
- Corticocancellous Allografts
- Osteochondral Allografts
- Massive Structural Allografts
- Demineralized Bone Matrix (DBM)
- Putty
- Gel
- Paste
- Injectable DBM
- Fibers/Strips/Sheets
- Cellular Bone Matrices (CBM)
- Mesenchymal Stem Cell (MSC)-Containing Allografts
- Viable Osteogenic Cell Allografts
- Cryopreserved Cellular Allografts
- Machined Allografts
- Others (Bone Chips, Bone Powder)
- Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Spinal Fusion
- Trauma & Long Bone
- Joint Reconstruction
- Craniomaxillofacial
- Dental
- Foot & Ankle
- Sports Medicine
- End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics/Dental Clinics
- Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- Spain
- Italy
- France
- Denmark
- Norway
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.1. Commodity flow analysis (Model 1)
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Bone Allografts Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Bone allografts: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Model
- 3.3.2. PESTLE Analysis
Chapter 4. Bone Allografts Market Segment Analysis, By Product, 2021 - 2033 (USD Million/Billion)
- 4.1. Definition and Scope
- 4.2. Product Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global bone allografts market, by Product, 2021 to 2033
- 4.5. Structural Allografts
- 4.5.1. Structural allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.5.2. Cortical Allografts
- 4.5.2.1. Cortical Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.5.3. Cancellous Allografts
- 4.5.3.1. Cancellous Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.5.4. Corticocancellous Allografts
- 4.5.4.1. Corticocancellous Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.5.5. Osteochondral Allografts
- 4.5.5.1. Osteochondral Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.5.6. Massive Structural Allografts
- 4.5.6.1. Massive Structural Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.6. Demineralized Bone Matrix (DBM)
- 4.6.1. Demineralized bone matrix (DBM) market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.6.2. Putty
- 4.6.2.1. Putty market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.6.3. Gel
- 4.6.3.1. Gel market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.6.4. Paste
- 4.6.4.1. Paste market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.6.5. Injectable DBM
- 4.6.5.1. Injectable DBM market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.6.6. Fibers/Strips/Sheets
- 4.6.6.1. Fibers/Strips/Sheets market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.7. Cellular Bone Matrices (CBM)
- 4.7.1. Cellular bone matrices (CBM) market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.7.2. Mesenchymal Stem Cell (MSC)-Containing Allografts
- 4.7.2.1. Mesenchymal Stem Cell (MSC)-Containing Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.7.3. Viable Osteogenic Cell Allografts
- 4.7.3.1. Viable Osteogenic Cell Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.7.4. Cryopreserved Cellular Allografts
- 4.7.4.1. Cryopreserved Cellular Allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.8. Machined Allografts
- 4.8.1. Machined allografts market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 4.9. Others (Bone Chips, Bone Powder)
- 4.9.1. Others (bone chips, bone powder) market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
Chapter 5. Bone Allografts Market Segment Analysis, By Application, 2021 - 2033 (USD Million/Billion)
- 5.1. Definition and Scope
- 5.2. Application Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global bone allografts market, by Application, 2021 to 2033
- 5.5. Spinal Fusion
- 5.5.1. Spinal fusion market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 5.6. Trauma & Long Bone
- 5.6.1. Trauma & long bone market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 5.7. Joint Reconstruction
- 5.7.1. Joint reconstruction market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 5.8. Craniomaxillofacial
- 5.8.1. Craniomaxillofacial market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 5.9. Dental
- 5.9.1. Dental market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 5.10. Foot & Ankle
- 5.10.1. Foot & ankle market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 5.11. Sports Medicine
- 5.11.1. Sports medicine market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
Chapter 6. Bone Allografts Market Segment Analysis, By End Use, 2021 - 2033 (USD Million/Billion)
- 6.1. Definition and Scope
- 6.2. End Use Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global bone allografts Market, by End Use, 2021 to 2033
- 6.5. Hospitals
- 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 6.6. Ambulatory Surgical Centers (ASCs)
- 6.6.1. Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
- 6.7. Specialty Clinics/Dental Clinics
- 6.7.1. Specialty clinics/dental clinics market estimates and forecasts, 2021 to 2033 (USD Million/Billion)
Chapter 7. Bone Allografts Market Segment Analysis, By Region, 2021 - 2033 (USD Million/Billion)
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Bone Allografts Market Share by Region, 2025 & 2033:
- 7.5. North America
- 7.5.1. North America bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.5.2. U.S.
- 7.5.2.1. U.S. bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.5.3. Canada
- 7.5.3.1. Canada bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.5.4. Mexico
- 7.5.4.1. Mexico bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6. Europe
- 7.6.1. Europe bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.2. UK
- 7.6.2.1. UK bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.3. Germany
- 7.6.3.1. Germany bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.4. France
- 7.6.4.1. France bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.5. Italy
- 7.6.5.1. Italy bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.6. Spain
- 7.6.6.1. Spain bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.7. Norway
- 7.6.7.1. Norway bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.8. Sweden
- 7.6.8.1. Sweden bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.6.9. Denmark
- 7.6.9.1. Denmark bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7.2. China
- 7.7.2.1. China bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7.3. India
- 7.7.3.1. India bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7.4. Australia
- 7.7.4.1. Australia bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7.5. South Korea
- 7.7.5.1. South Korea bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7.6. Thailand
- 7.7.6.1. Thailand bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.7.1. Japan
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.8.2. Argentina
- 7.8.2.1. Argentina bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.8.1. Brazil
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.9.3. UAE
- 7.9.3.1. UAE bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait bone allografts market, 2021 - 2033 (USD Million/Billion)
- 7.9.1. South Africa
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Stryker
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Zimmer Biomet
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Smith+Nephew
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Medtronic
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Lynch Biologics, LLC
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Biomatlante
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Johnson & Johnson Services, Inc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Royal Biologics
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Baxter
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Xtant Medical
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.1. Stryker
